Goat anti-Human Ig (Chain kappa), (Light Chain) Antibody (DyLight 800)
Quick Overview for Goat anti-Human Ig (Chain kappa), (Light Chain) Antibody (DyLight 800) (ABIN612185)
Target
Conjugate
Application
-
-
Binding Specificity
- Chain kappa, Light Chain
-
Reactivity
- Human
-
Host
- Goat
-
Specificity
- Based on IEP, this antibody reacts with: kappa (κ) light chains on all human immunoglobulins
-
Cross-Reactivity (Details)
- Based on IEP, no reactivity is observed to: non-immunoglobulin human serum immunoglobulins and heavy chains on all human immunoglobulins and lambda (λ) light chains on all human immunoglobulins
-
Characteristics
-
Concentration: 1.0 mg/mL (E 1 % at 280 nm = 13.0)
Conjugate: DyLight 800 (Ex = 770 nm, Em = 794 nm) -
Purification
- Affinity purified using solid phase human Kappa (κ) Chain
-
Purity
- > 95 % based on SDS-PAGE
-
Immunogen
- Purified human kappa (kappa) light chain
-
-
-
-
Application Notes
- This Conjugate is suitable for immunomicroscopy and flow cytometry. The optimal working dilution should be determined by the investigator. Suggested starting dilution(s): 1:20 - 1:2,000 for most applications
-
Comment
-
DyLight is a trademark of Thermo Fisher Scientific, Inc. and its subsidiaries.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Rehydrate with 0.55 mL of deionized water and let stand 30 minutes at room temperature to dissolve. Centrifuge to remove any particulates. Prepare fresh working dilution daily.
-
Concentration
- 1.0 mg/mL
-
Buffer
- 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store freeze-dried powder at 2-8 °C. Product is stable for up to 4 weeks at 2-8°C after rehydration. For extended storage after rehydration, add an equal volume of glycerol and store at -20°C.
-
-
- Ig
-
Alternative Name
- Immunoglobulin Ig
Target
-